Index Venture Associates III Ltd

CIK 1503683 · last filed 2019-06-19

Index Venture Associates III Ltd is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider sold $1.9M of NERV on Jun 19, 2019. Across all open-market trades the lifetime net is −$74.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions. The firm reports its address in St. Helier, Channel Islands, Y9. 17 SEC filings were submitted jointly with (Jersey) SLP Yucca.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.19M

Companies

2

Total Filings

7

Lifetime Open-Market Net

-$74.25M

Filer Profile

Reported Address

5TH FLOOR, 44 ESPLANADE
ST. HELIER, CHANNEL ISLANDS, Y9 JE1 3FG

Phone

441534605643

State of Incorporation

Jersey

Related Filers

(Jersey) SLP Yucca — 17 joint filings, latest 2019-06-26

Index Venture Associates IV Ltd — 14 joint filings, latest 2019-06-26

Index Venture Associates V Ltd — 14 joint filings, latest 2019-06-26

Index Ventures III (Delaware) L.P. — 8 joint filings, latest 2014-02-13

Yucca Partners L.P. Jersey Branch — 5 joint filings, latest 2012-02-01

INDEX VENTURES LIFE VI (JERSEY) L.P. — 3 joint filings, latest 2014-02-13

Index Venture Associates VI Ltd — same reported address

Index Venture Growth Associates I Ltd — same reported address

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
NERV	10%+ Owner	532,085	$4.12	$2.19M	-$7.45M	5	2019-06-19
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	10%+ Owner	2,131,827	—	—	-$66.80M	2	2011-08-02

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-06-19	NERV	Sell (S)	−423,672	-$1.88M	EDGAR
2019-06-13	NERV	Sell (S)	−240,204	-$1.13M	EDGAR
2018-10-01	NERV	Sell (S)	−265,092	-$3.34M	EDGAR
2016-08-12	NERV	Sell (S)	−4,000,000	-$40.00M	EDGAR
2014-07-09	NERV	Mixed	+7,187,328	$43.12M	EDGAR
2011-08-02	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−183,940	-$2.69M	EDGAR
2011-07-01	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−4,388,615	-$64.11M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.